AVANIR Pharmaceuticals (FRA:AV2B) Change In Inventory : €0.05 Mil (TTM As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is AVANIR Pharmaceuticals Change In Inventory?

AVANIR Pharmaceuticals's change in inventory for the quarter that ended in Sep. 2014 was €-0.03 Mil. It means AVANIR Pharmaceuticals's inventory increased by €0.03 Mil from Jun. 2014 to Sep. 2014 .

AVANIR Pharmaceuticals's change in inventory for the fiscal year that ended in Sep. 2014 was €0.06 Mil. It means AVANIR Pharmaceuticals's inventory declined by €0.06 Mil from Sep. 2013 to Sep. 2014 .

AVANIR Pharmaceuticals's Total Inventories for the quarter that ended in Sep. 2014 was €0.62 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. AVANIR Pharmaceuticals's Inventory Turnover for the quarter that ended in Sep. 2014 was -1.14.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. AVANIR Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Sep. 2014 was 0.02.

AVANIR Pharmaceuticals Change In Inventory Historical Data

The historical data trend for AVANIR Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVANIR Pharmaceuticals Change In Inventory Chart

AVANIR Pharmaceuticals Annual Data

Trend

Sep05

Sep06

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Sep13

Sep14

Change In Inventory

Get a 7-Day Free Trial

-0.04

-0.12

-0.22

-0.13

0.06

AVANIR Pharmaceuticals Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Change In Inventory	Get a 7-Day Free Trial															-0.03	0.08	-0.03	0.03	-0.03

AVANIR Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.05 Mil.

AVANIR Pharmaceuticals (FRA:AV2B) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

AVANIR Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.5625	/	-0.644	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

AVANIR Pharmaceuticals's Inventory Turnover for the quarter that ended in Sep. 2014 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	-0.644	/	0.5625
	=	-1.14

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

AVANIR Pharmaceuticals's Inventory to Revenue for the quarter that ended in Sep. 2014 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.5625	/	25.379
	=	0.02

AVANIR Pharmaceuticals Change In Inventory Related Terms

Thank you for viewing the detailed overview of AVANIR Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

AVANIR Pharmaceuticals (FRA:AV2B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AVANIR Pharmaceuticals (FRA:AV2B) » Definitions » Change In Inventory

Traded in Other Exchanges

N/A

Address

Website

http://www.avanir.com

Avanir Pharmaceuticals was incorporated in California in August 1988 and was reincorporated in Delaware in March 2009. The Company is a biopharmaceutical company focused on acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders. The Company commenced promotion of NUEDEXTA in the United States in February 2011. The Company is also studying AVP-923 for use in different types of neuropathic pain. NUEDEXTA is the first and only FDA-approved treatment for pseudobulbar affect. NUEDEXTA is an combination of two components: dextromethorphan hydrobromide, the ingredient that is harmacologically active in the central nervous system, and quinidine sulfate, a metabolic inhibitor enabling dextromethorphan to reach therapeutic plasma concentrations. The Company currently markets NUEDEXTA to approximately 10,000 physicians and other healthcare providers who specialize in psychiatry, neurology or geriatric medicine and practice in outpatient or long-term care settings. NUEDEXTA may face competition from several products: Antidepressants, including Prozac, Celexa, Zoloft, Paxil, Elavil and Pamelor and others; Atypical antipsychotic agents, including Zyprexa, Risperdal, Seroquel, Abilify, Geodon and others; and Miscellaneous agents, including Symmetrel, Lithium and others. The Company is subject to regulation under the Occupational Safety and Health Act, the Environmental Protection Act, the Toxic Substance Control Act, the Export Control Act and other present and future laws of general application.

AVANIR Pharmaceuticals (FRA:AV2B) Headlines

No Headlines